REG - Reabold Resources - Completion of Parta Exploration Licence Farm-In

Reabold ResourcesAnnouncement

17/07/2019 07:05

RNS Number : 7972F
Reabold Resources PLC
17 July 2019
 


17 July 2019
 
Reabold Resources Plc
("Reabold" or the "Company")
 
Completion of Parta Exploration Licence Farm-In
 
 
Reabold, the AIM investing company which focusses on investments in pre-cash flow upstream oil and gas projects, is pleased to note the announcement made by ADX Energy Ltd ("ADX") this morning, regarding the completion of the farm out of a 50 per cent. interest in the Parta Exploration Licence to Parta Energy Pty Ltd, which will earn its interest through funding the first US$1.5 million of a planned 3D seismic acquisition programme.
 
Danube Petroleum Limited, in which Reabold owns a 37.5 per cent. interest, will subsequently own 50 per cent. of the Parta exploration licence and 100 per cent. of the defined 19.4km2 Sole Risk Area, which includes the Iecea Mare Production licence, where ADX is planning to commence drilling of the IM1 appraisal well in the coming weeks.
 
The full release issued by ADX Energy can be viewed here: https://adx-energy.com/documents/us1.5million-romanian-farm-in-completed.pdf
 
For further information please contact:
 




Reabold Resources plc
Stephen Williams
Sachin Oza


c/o Camarco
+44 (0) 20 3757 4980




Strand Hanson Limited (Nominated and Financial Adviser)
James Spinney
Rory Murphy
James Dance


 +44 (0)20 7409 3494
 
  




Camarco
James Crothers
Ollie Head
Billy Clegg


+44 (0) 20 3757 4980




Whitman Howard Limited (Joint Broker)
Nick Lovering
Grant Barker
 


+44 (0) 20 7659 1234 




Turner Pope Investments (TPI) Ltd (Joint Broker)
Andy Thacker


+44 (0) 20 3621 4120




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DRLLIFVEDEIDLIA